Jeffrey M Jonas Sage Therapeutics, Inc. (SAGE) insider trading activity

Jeffrey M Jonas is of Sage Therapeutics, Inc.. Currently has a direct ownership of 128,046 shares of SAGE, which is worth approximately $718,338. The most recent transaction as insider was on Nov 28, 2023, when has been sold 3,935 shares (Common Stock) at a price of $19.27 per share, resulting in proceeds of $75,827. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 128K

0% 3M change

0% 12M change

Total Value Held $718,338

JEFFREY M JONAS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 28 2023	SELL Payment of exercise price or tax liability	$75,827 $19.27 p/Share	3,935 Reduced 2.98%	128,046 Common Stock
Nov 28 2023	BUY Grant, award, or other acquisition	-	10,000 Added 7.04%	131,981 Common Stock
Feb 10 2023	SELL Open market or private sale	$520,325 $44.69 p/Share	11,643 Reduced 8.71%	121,981 Common Stock
Feb 10 2023	BUY Exercise of conversion of derivative security	$5,239 $0.45 p/Share	11,643 Added 8.01%	133,624 Common Stock
Feb 03 2023	SELL Payment of exercise price or tax liability	$63,016 $44.16 p/Share	1,427 Reduced 1.16%	121,981 Common Stock
Feb 03 2023	BUY Grant, award, or other acquisition	-	5,100 Added 3.97%	123,408 Common Stock
Jan 03 2023	BUY Exercise of conversion of derivative security	$71,603 $28.63 p/Share	2,501 Added 2.07%	118,308 Common Stock
Apr 27 2022	BUY Exercise of conversion of derivative security	$13,925 $0.45 p/Share	30,944 Added 21.09%	115,807 Common Stock
Feb 17 2022	BUY Exercise of conversion of derivative security	$1,800 $0.45 p/Share	4,000 Added 4.5%	84,863 Common Stock
Oct 19 2021	SELL Payment of exercise price or tax liability	$176,228 $40.29 p/Share	4,374 Reduced 5.13%	80,863 Common Stock
Oct 19 2021	BUY Grant, award, or other acquisition	-	10,000 Added 10.5%	85,237 Common Stock
Jun 16 2021	BUY Exercise of conversion of derivative security	$5,400 $0.45 p/Share	12,000 Added 13.76%	75,237 Common Stock
Jun 15 2021	SELL Payment of exercise price or tax liability	$181,868 $58.8 p/Share	3,093 Reduced 4.66%	63,237 Common Stock
Jun 15 2021	BUY Grant, award, or other acquisition	-	10,000 Added 13.1%	66,330 Common Stock
Jan 27 2021	BUY Exercise of conversion of derivative security	$810 $0.45 p/Share	1,800 Added 3.1%	56,330 Common Stock

Also insider at

GBIO

Generation Bio Co. Healthcare

KRTX

Karuna Therapeutics, Inc. Healthcare

JMJ

Jeffrey M Jonas

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SAGE shares.

Notify only if

Value

Insider Trading

Get notified when an Sage Therapeutics, Inc. insider buys or sells SAGE shares.

Notify only if

Operation

Value

Type

News

Receive news related to Sage Therapeutics, Inc.

Track Activities on SAGE

Account